Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice

Behavioural Brain Research
G Telegdy, Andrew V Schally

Abstract

Antagonists of growth hormone-releasing hormone (GH-RH), such as MZ-4-71 suppress the secretion of GH. These findings suggest that GH-RH antagonists could be used for the therapy of disorders characterized by excessive GH secretion. It has been also demonstrated that MZ-4-71 displays antidepressant effects in a modified forced swimming test in mice, exerts anxiolytic effects in an elevated plus maze test, improves memory consolidation in passive avoidance learning, and corrects the impairment of memory consolidation caused by β-amyloid (25-35) in mice. However, little is known about the mechanisms of action of MZ-4-71 on brain functions. In the present work, the involvement of the adrenergic, serotonergic and GABA-ergic receptors in the anxiolytic action of MZ-4-71 was studied in an elevated plus maze. Mice were pretreated with a nonselective α-adrenergic receptor antagonist, phenoxybenzamine, an α1/α2β-adrenergic receptor antagonist, prazosin, an α2-adrenergic receptor antagonist, yohimbine, a mixed 5-HT1/5-HT2 serotonergic receptor antagonist, methysergide, a non-selective 5-HT2 serotonergic receptor antagonist, cyproheptadine, and a γ-aminobutyric acid subunit (GABA-A) receptor antagonist, bicuculline. Phenoxybenzamine, praz...Continue Reading

References

Jan 1, 1984·Psychopathology·S J Enna
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·M ZarandiA V Schally
Oct 22, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ferenc ObalJames M Krueger
Aug 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Laura B JaegerAndrew V Schally
Nov 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Alexandre HavtCelia A Kanashiro
Dec 18, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Andrew V SchallyJörg B Engel
Dec 8, 2010·Proceedings of the National Academy of Sciences of the United States of America·William A BanksAndrew V Schally
Dec 31, 2010·Current Opinion in Biotechnology·Matthias Heinemann, Uwe Sauer
Jun 16, 2011·Behavioural Brain Research·Gyula TelegdyAndrew V Schally
Sep 29, 2011·Expert Opinion on Pharmacotherapy·Jennifer A ReinholdFalk W Lohoff

❮ Previous
Next ❯

Citations

Jun 8, 2013·Behavioural Brain Research·G Telegdy, A Adamik
Jul 17, 2014·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Sheila LeoneLuigi Brunetti
Feb 8, 2014·Behavioural Brain Research·Gyula Telegdy, Miklós Jászberényi
Jul 31, 2013·Regulatory Peptides·G Telegdy, A Adamik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.